Publicacións nas que colabora con S. Llamas Velasco (25)

2023

  1. Cerebral amyloid angiopathy–related inflammation: clinical features and treatment response in a case series

    Neurologia, Vol. 38, Núm. 8, pp. 550-559

  2. Static first-minute-frame (FMF) PET imaging after 18F-labeled amyloid tracer injection is correlated to [18F]FDG PET in patients with primary progressive aphasia

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 4, pp. 211-217

2022

  1. Hereditary cerebral small vessel disease: Assessment of a HTRA1 variant using protein stability predictors and 3D modelling

    European Journal of Medical Genetics, Vol. 65, Núm. 8

  2. Heterozygous and Homozygous Variants in SORL1 Gene in Alzheimer’s Disease Patients: Clinical, Neuroimaging and Neuropathological Findings

    International Journal of Molecular Sciences, Vol. 23, Núm. 8

2021

  1. Early-Onset Dementia Associated with a Heterozygous, Nonsense, and de novo Variant in the MBD5 Gene

    Journal of Alzheimer's Disease, Vol. 84, Núm. 1, pp. 73-78

  2. Expanding the clinical and genetic spectrum of SQSTM1-related disorders in family with personality disorder and frontotemporal dementia

    Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, Vol. 22, Núm. 7-8, pp. 552-560

  3. Physical activity and risk of Parkinson's disease and parkinsonism in a prospective population-based study (NEDICES)

    Preventive Medicine Reports, Vol. 23

  4. Report by the Spanish Foundation of the Brain on the social impact of Alzheimer disease and other types of dementia

    Neurologia

  5. Texture-based analysis of 18F-labeled amyloid PET brain images

    Applied Sciences (Switzerland), Vol. 11, Núm. 5, pp. 1-11

2020

  1. Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study

    Journal of Alzheimer's Disease, Vol. 78, Núm. 4, pp. 1367-1372

  2. Correction to: Platelet Proteomic Analysis Revealed Differential Pattern of Cytoskeletal- and Immune-Related Proteins at Early Stages of Alzheimer’s Disease (Molecular Neurobiology, (2018), 55, 12, (8815-8825), 10.1007/s12035-018-1039-3)

    Molecular Neurobiology

  3. Decreased salivary lactoferrin levels are specific to Alzheimer's disease

    EBioMedicine, Vol. 57, pp. 102834

  4. Kynurenic acid levels are increased in the CSF of Alzheimer’s disease patients

    Biomolecules, Vol. 10, Núm. 4

  5. Non-steroidal anti-inflammatory drugs as candidates for the prevention or treatment of alzheimer’s disease: Do they still have a role?

    Current Alzheimer Research, Vol. 17, Núm. 11, pp. 1013-1022

2019

  1. Bilingualism in primary progressive aphasia a retrospective study on clinical and language characteristics

    Alzheimer Disease and Associated Disorders, Vol. 33, Núm. 1, pp. 47-53

  2. Neurological disorders in central Spain, second survey: Feasibility pilot observational study

    Journal of Medical Internet Research, Vol. 21, Núm. 1

2018

  1. Platelet Proteomic Analysis Revealed Differential Pattern of Cytoskeletal- and Immune-Related Proteins at Early Stages of Alzheimer’s Disease

    Molecular Neurobiology, Vol. 55, Núm. 12, pp. 8815-8825

  2. Slowly progressive behavioral frontotemporal dementia with C9orf72 mutation. Case report and review of the literature

    Neurocase, Vol. 24, Núm. 1, pp. 68-71

  3. TARDBP mutation associated with semantic variant primary progressive aphasia, case report and review of the literature

    Neurocase, Vol. 24, Núm. 5-6, pp. 301-305

2017

  1. Amyloid pet in primary progressive aphasia: case series and systematic review of the literature

    Journal of Neurology, Vol. 264, Núm. 1, pp. 121-130